An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

Clinical trial NCT02065973 · COMPLETED

Trial details

NCT number: NCT02065973
Sponsor: PDS Biotechnology Corp.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

High-risk HPV Infection and Biopsy-proven CIN1

Start date: 2014-02-01
Primary completion: 2015-12-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.